What Is a Dexcom Receiver and How Does It Work?

A Dexcom receiver is a small, dedicated handheld device that wirelessly displays real-time glucose readings from a Dexcom continuous glucose monitoring (CGM) sensor worn on the body. It serves as the screen and brain of the system for people who prefer not to use a smartphone, showing current glucose values, trend arrows, and customizable alerts around the clock. While many Dexcom users now rely on a phone app instead, the receiver remains a core component of the CGM setup and the only option for some users.

The Three Parts of a Dexcom CGM System

To understand the receiver, you need to see how it fits into the broader system. A Dexcom CGM has three main components that work together. The first is the sensor, a tiny flexible filament inserted just beneath the skin (usually on the back of the upper arm or the abdomen) that measures glucose in the interstitial fluid, the thin layer of fluid between your cells. The second is the transmitter, a small device that snaps onto the sensor and converts the raw electrochemical signal into a digital reading, then sends it wirelessly. The third is the display device, which is either the Dexcom receiver or a compatible smartphone running the Dexcom app.

The receiver itself looks like a small touchscreen device, roughly the size of a credit card but thicker. It communicates with the transmitter via Bluetooth Low Energy and refreshes your glucose reading every five minutes. That five-minute cycle is constant: day and night, whether you’re looking at the screen or not, the receiver is collecting and storing data. It holds up to 24 hours of trend graphs so you can scroll back and review patterns.

How Glucose Data Travels from Sensor to Screen

The process starts under your skin. The sensor’s filament is coated with an enzyme that reacts with glucose in the interstitial fluid, generating a tiny electrical current. Higher glucose concentrations produce a stronger current. The transmitter sitting on top of the sensor measures that current and applies a calibration algorithm to convert it into a glucose value expressed in mg/dL or mmol/L, depending on your settings.

That converted value, along with the rate and direction of change, is sent over Bluetooth to the receiver every five minutes. The receiver then runs its own software to generate what you actually see on screen: a number, a trend arrow, and a graph. The trend arrow is one of the most useful features. A flat arrow means glucose is relatively stable. Arrows angling up or down indicate moderate change, and straight vertical arrows mean glucose is rising or falling fast. These arrows help you decide whether to eat, take insulin, or wait.

One thing worth knowing is that interstitial fluid glucose lags behind blood glucose by several minutes. If your blood sugar is dropping quickly after a meal correction, the receiver’s number may still read higher than a fingerstick would. The lag is usually around five to ten minutes and is most noticeable during rapid changes. During stable periods, the two readings track closely.

Receiver Versus the Smartphone App

Dexcom offers a free app for both iOS and Android that does everything the receiver does, plus a few extras like sharing data with followers (a family member or partner can watch your glucose remotely). So why would anyone choose the dedicated receiver?

The most common reason is phone compatibility. Not every smartphone model supports the Dexcom app, and some users have older phones or budget models that fall outside the compatibility list. The receiver sidesteps that issue entirely because it is purpose-built for the job. A second reason is reliability. Phones can run out of battery, lose Bluetooth connections when running many apps, or install software updates that temporarily break the Dexcom app. The receiver has one job, so it tends to hold its connection more consistently. A third reason is simplicity: some users, particularly older adults and children, prefer a device that does nothing but show glucose data without the distractions of a phone.

Research on CGM usability among elderly patients found the technology was highly usable and acceptable, with an average adherence rate of about 81%, suggesting that even people who aren’t tech-savvy can manage the system effectively when the interface stays simple and focused.

You can also use both at the same time. The transmitter can broadcast to the receiver and a phone simultaneously, so some people keep the receiver on their nightstand for overnight alerts and carry their phone during the day. The one limitation is that only one receiver can be paired to a transmitter at a time, so you cannot use two receivers.

Alerts and Predictive Alarms

The receiver does more than passively display data. It actively watches for dangerous glucose levels and alerts you with audible alarms and on-screen notifications. You can set a high alert (for example, above 250 mg/dL) and a low alert (below 70 mg/dL), and the receiver will sound off when your glucose crosses those thresholds.

Starting with the Dexcom G6, the system also includes a predictive low glucose alert. This feature uses an algorithm to predict whether your glucose will drop to 55 mg/dL or below within the next 20 minutes, giving you a warning before you’re actually in hypoglycemic territory.

1PubMed Central. Real-World Hypoglycemia Avoidance with a Continuous Glucose Monitoring System’s Predictive Low Glucose Alert

That 20-minute head start can be the difference between calmly eating a few glucose tablets and experiencing a full-blown low with confusion, shakiness, or worse. The alert works on the receiver just as it does on the phone app.

There is, however, a tension between useful alerts and too many alerts. Research on diabetes device alarms has documented a phenomenon called alarm fatigue, where people who receive too many alarms become desensitized and start ignoring them, even when they shouldn’t. This is a real consideration when setting up a receiver. Setting thresholds too tightly (say, alerting any time glucose rises above 140 mg/dL) can lead to so many notifications that you start tuning them out, potentially missing the ones that actually matter.

2PubMed Central. “Turn it off!”: diabetes device alarm fatigue considerations for the present and the future

Most diabetes educators recommend starting with wider thresholds and tightening them gradually as you get comfortable with the system, rather than going aggressive from day one.

How Accurate Is What the Receiver Shows You

The number you see on the receiver screen is only useful if it closely matches your actual blood glucose. CGM accuracy is measured using something called Mean Absolute Relative Difference, or MARD, which is essentially the average percentage by which the sensor reading differs from a lab-grade blood glucose measurement. A lower MARD means better accuracy.

In a clinical study of the Dexcom G7 in adults, the overall MARD was 8.2% for sensors placed on the arm and 9.1% for sensors placed on the abdomen. Agreement rates within 20% of the reference value were about 95% for arm placement and 93% for abdominal placement.

3PubMed Central. Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes

In practical terms, if your true blood glucose is 150 mg/dL, the receiver will typically show a value within about 12 to 14 mg/dL of that, and it will be within 30 mg/dL the vast majority of the time.

Accuracy can shift in certain settings. A study of hospitalized children with type 1 diabetes found an overall MARD of about 10.6%, somewhat wider than the adult outpatient numbers but still within a clinically useful range.

4PubMed Central. Clinical accuracy of Dexcom G6 and G7 continuous glucose monitors in hospitalized pediatric patients with type 1 diabetes: a real-world study

Similarly, a study of the Dexcom One+ (a more affordable variant using the same core sensor technology) in adult patients hospitalized in a cardiac intensive care unit found a MARD of about 11.6%.

5PubMed. Accuracy of Dexcom One+ in Patients with Diabetes or Stress Hyperglycemia Hospitalized in Cardiac Intensive Care Unit

Hospital environments introduce factors that can widen the gap: medications like acetaminophen (in older sensor generations), poor circulation, and rapidly changing blood sugar from IV insulin or dextrose drips. The takeaway is that the receiver’s readings are reliable enough to guide most day-to-day insulin decisions in outpatient life, but during acute illness or hospitalization, fingerstick confirmation may still be warranted.

FDA Classification and What “No Fingersticks” Actually Means

Dexcom systems, including the G6, G7, and Dexcom ONE+ in certain markets, have been cleared by the FDA as integrated CGM (iCGM) devices. That classification matters because it means the system has met a defined accuracy standard that allows it to be used nonadjunctively. In plain language, nonadjunctive means you can make insulin dosing decisions based on the receiver’s glucose reading without having to confirm with a fingerstick blood test first.

6PubMed Central. Importance of FDA-Integrated Continuous Glucose Monitors to Ensure Accuracy of Continuous Glucose Monitoring

This was a significant shift from earlier CGM generations, which regulators considered adjunctive only, meaning they could show you your glucose but you were still supposed to prick your finger before making treatment decisions. The iCGM designation eliminated that requirement for daily use, which is why Dexcom markets its current systems as requiring zero fingerstick calibrations.

That said, there are still moments when a fingerstick is smart. If your symptoms don’t match what the receiver says (you feel shaky but the screen shows 120 mg/dL, for example), a fingerstick is the right call. The same goes for the first 24 hours after inserting a new sensor, when readings can be less stable as the sensor settles in. The receiver will sometimes display a “sensor error” message during these periods, which is its way of telling you the reading isn’t reliable enough to show.

How the Receiver Connects to Insulin Pumps and Automated Delivery

For people who use an insulin pump, the CGM data flowing from the sensor can do more than just display numbers. In automated insulin delivery (AID) systems, the CGM reading feeds directly into the pump’s algorithm, which adjusts basal insulin delivery in real time. The receiver is not the middleman in this process. In most AID configurations, the transmitter communicates directly with the pump (or with a phone running the AID algorithm), and the receiver serves as an optional secondary display.

A retrospective study comparing glycemic outcomes in AID users found that those using Dexcom G6 or G7 sensors achieved somewhat higher time in range compared to users of another major CGM brand, though the study was small.

7CrossRef API / Diabetes. Retrospective Analysis and Comparison of Dexcom and Libre Continuous Glucose Monitoring Systems in Automated Insulin Delivery Users: The Delica_01 Study

Whether that difference comes from sensor accuracy, algorithm tuning, or user behavior is hard to untangle, but it underscores that the quality of CGM data matters for automated systems. A receiver showing you accurate, timely data is one piece of the puzzle. The other piece is how well that data integrates with whatever is controlling your insulin.

If you use the receiver alongside an AID system, its role is informational rather than functional. You can glance at it to see what your glucose is doing, but the pump is getting its data straight from the transmitter. Some users find this reassuring because it gives them a second screen to monitor things, especially overnight.

Practical Tips for Getting the Most Out of a Receiver

Placement of the sensor affects what the receiver shows you. Arm placement has slightly better accuracy numbers than abdominal placement in studies, so if you have the choice and no strong preference, the back of the upper arm is a good default. That said, abdomen placement is still well within clinical accuracy, and some people find it more comfortable or easier to insert there.

Battery life on the receiver is decent but not infinite. Plan to charge it daily, or at least every other day, so it doesn’t die overnight when alerts are arguably most important. If the receiver loses power, it loses its Bluetooth connection, and you’ll have a gap in your data. The receiver will pick back up when you turn it on again, but it can’t retroactively fill in readings it missed.

Keep the receiver within about 20 feet of the transmitter. Bluetooth signals can pass through clothing and blankets without issue but may struggle with walls or certain body positions. If the receiver sits on a nightstand across the room while you sleep, you might occasionally get a “signal loss” message. Moving it closer usually fixes the problem.

Water is another consideration. The sensor and transmitter are designed to be water-resistant and can be worn in the shower or while swimming. The receiver, however, is not waterproof. It is an electronic touchscreen device and should be treated accordingly. Leave it on the pool deck or in a dry bag, and check it when you get out.

When Compression Affects Readings

One quirk that confuses new CGM users is compression lows. If you sleep on the arm where your sensor is placed, the pressure can compress the tissue around the sensor filament and temporarily reduce glucose flow to the area. The result is a falsely low reading on the receiver, sometimes dramatically so. You might wake up to an urgent low alarm showing 55 mg/dL when your actual blood sugar is perfectly normal.

These dips have a distinctive appearance on the trend graph: a sharp, steep drop that resolves quickly once you shift position. Over time, you learn to recognize them, and they become less alarming. If you’re ever unsure whether a low reading is real or caused by pressure, a quick fingerstick settles it. Some people solve the problem by placing the sensor on the abdomen when they’re a side sleeper, or simply switching which arm they use so the sensor isn’t always on the side they sleep on.

Receiver Versus Dexcom ONE and Regional Variants

Dexcom sells several product lines globally, and the receiver situation varies by model and region. The Dexcom G7, the company’s latest system, made a notable design change: the transmitter and sensor are combined into a single disposable unit, which is slimmer and faster to warm up than earlier generations. The G7 receiver is a standalone touchscreen device similar to previous versions but updated for the new hardware.

The Dexcom ONE and Dexcom ONE+ are lower-cost alternatives available in certain markets outside the United States (and more recently inside the U.S. as well). They use the same underlying sensor technology but have a simplified software experience with fewer customizable alert options. The ONE+ can work with a dedicated receiver or a smartphone app, just like the G7, though the receiver’s interface is slightly stripped down. If you’re choosing between models, the sensor accuracy is comparable across the lineup. The differences lie primarily in alert customization, sharing features, and compatibility with insulin pump systems.

For people whose insurance covers a specific model, or who are paying out of pocket in a market where the ONE+ is significantly cheaper, the decision often comes down to whether you need the advanced alert features and pump compatibility that the G7 offers. The receiver hardware works the same fundamental way across all current Dexcom systems: it receives a Bluetooth signal from the transmitter, processes it, and shows you your glucose.